🔎 Trials Near Me

Home › Myelofibrosis › Ohio › Cleveland

Myelofibrosis clinical trials in Cleveland, OH

9 studies for Myelofibrosis are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

RecruitingPhase 3
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

RecruitingPhase 1/2
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05320198

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

RecruitingPhase 1/2
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT06773195

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

RecruitingPhase 2
  • The Cleveland Clinic Foundation, Cleveland
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT05835466

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Apr 17, 2026 · NCT06034002

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

RecruitingPhase 2
  • Cleveland Clinic, Cleveland
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT05980806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

RecruitingPhase 3
  • Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland
  • Cleveland Clinic, Cleveland
  • Hillcrest Hospital - Cleveland Clinic, Mayfield Heights · 12 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT06479135

Myelofibrosis trials in other cities

Other studies in Cleveland

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.